Nuvalent (NUVL) Payables (2020 - 2026)
Nuvalent (NUVL) reported Payables of $22.1 million for Q1 2026, down 15.4% on a YoY basis from $26.2 million in Q1 2025, and down 26.6% quarter-over-quarter from $30.2 million in Q4 2025.
Nuvalent (NUVL) Payables (2020 - 2026) Analysis & Trends
Nuvalent has reported Payables for 7 years, with the latest figure at $22.1 million in Q1 2026.
- For the quarter ending Q1 2026, Payables fell 15.4% year-over-year to $22.1 million; the trailing twelve-month figure through Mar 2026 stood at $22.1 million (down 15.4% YoY), and the FY2025 full-year result was $30.2 million, up 477.19% from the prior year.
- Payables for Q1 2026 stood at $22.1 million, down from $30.2 million in the prior quarter.
- The five-year high for Payables was $30.2 million in Q4 2025, with the low at $4.0 million in Q2 2022.
- Historically, Payables has averaged $12.3 million across 5 years, with a median of $9.3 million in 2023.
- Annual changes were most pronounced in 2024 — Payables plunged 43.66% — and 2025, when it surged 477.19%.
- Nuvalent's Payables stood at $7.2 million in 2022, then gained by 28.9% to $9.3 million in 2023, then plunged by 43.66% to $5.2 million in 2024, then surged by 477.19% to $30.2 million in 2025, then fell by 26.6% to $22.1 million in 2026.
- The last three Payables figures came in at $22.1 million (Q1 2026), $30.2 million (Q4 2025), and $22.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 8.69 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 34.55 Mn |
| 10 | Nuvalent | 9.70 Bn | 9.70 Bn | - | 22.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.14 Mn |
| Dec 31, 2025 | 30.16 Mn |
| Sep 30, 2025 | 22.01 Mn |
| Jun 30, 2025 | 13.34 Mn |
| Mar 31, 2025 | 26.17 Mn |
| Dec 31, 2024 | 5.23 Mn |
| Sep 30, 2024 | 15.93 Mn |
| Jun 30, 2024 | 7.40 Mn |
| Mar 31, 2024 | 13.40 Mn |
| Dec 31, 2023 | 9.27 Mn |
| Sep 30, 2023 | 9.78 Mn |
| Jun 30, 2023 | 8.12 Mn |
| Mar 31, 2023 | 6.43 Mn |
| Dec 31, 2022 | 7.20 Mn |
| Sep 30, 2022 | 4.62 Mn |
| Jun 30, 2022 | 4.03 Mn |
| Mar 31, 2022 | 4.25 Mn |
| Dec 31, 2021 | 2.89 Mn |
| Sep 30, 2021 | 2.53 Mn |
| Jun 30, 2021 | 3.80 Mn |